Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Jessie Ehrisman"'
Autor:
Ashley E. Veade, Jonathan Foote, Jessie Ehrisman, Gloria Broadwater, Brittany A. Davidson, Paula S. Lee, Angeles Alvarez Secord, Andrew Berchuck, Laura J. Havrilesky
Publikováno v:
World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-8 (2019)
Abstract Objective To investigate the predictive value of lymphovascular space invasion (LVSI) for nodal recurrence and overall survival (OS) in patients with stage I endometrioid endometrial cancer (EC) following surgical staging that included adequ
Externí odkaz:
https://doaj.org/article/2a353b90811b4b2bbd9a63e52edccf47
Autor:
Brittany A. Davidson, Jonathan Foote, Leslie H. Clark, Gloria Broadwater, Jessie Ehrisman, Paola Gehrig, Whitney Graybill, Angeles Alvarez Secord, Laura J. Havrilesky
Publikováno v:
Gynecologic Oncology Reports, Vol 17, Iss C, Pp 3-6 (2016)
The objective of this study is to evaluate the association between tumor grade and response to chemotherapy in patients with endometrioid endometrial adenocarcinoma. Patients with advanced or recurrent endometrioid endometrial adenocarcinoma of known
Externí odkaz:
https://doaj.org/article/1bc98b048ee345d09bb687159bee622f
Autor:
Jessie Ehrisman, Angeles Alvarez Secord, Andrew Berchuck, Paula S. Lee, Nicola Di Santo, Micael Lopez-Acevedo, Gloria Broadwater, Fidel A. Valea, Laura J. Havrilesky
Publikováno v:
Gynecologic Oncology Reports, Vol 17, Iss C, Pp 69-71 (2016)
Objective: To determine the rate and performance of sentinel lymph node (SLN) mapping among women with high-risk endometrial cancers. Methods: Patients diagnosed between 2012 and 2015 with uterine cancer of grade 3 endometrioid, clear cell, serous or
Externí odkaz:
https://doaj.org/article/a3df9b20172e4561828412c8d0c960a4
Publikováno v:
The Patient - Patient-Centered Outcomes Research. 13:401-408
In stated-preference research, the conventional approach to describing study attributes is through text, often with easy-to-understand graphics. More recently, researchers have begun to present attribute descriptions and content in videos. Some exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3182d02b47295cb0b98e6ba1fa90ffa7
https://doi.org/10.1007/s40271-020-00416-9
https://doi.org/10.1007/s40271-020-00416-9
Autor:
Angeles Alvarez Secord, Juan Marcos Gonzalez, F. Reed Johnson, Shelby D. Reed, Jessie Ehrisman, Stephanie Lim, Jui-Chen Yang, Laura J. Havrilesky, Amelia Lorenzo
Publikováno v:
Gynecologic Oncology. 156:561-567
Objective To measure preferences of women with ovarian cancer regarding risks, side effects, costs and benefits afforded by maintenance therapy (MT) with a poly ADP ribose polymerase (PARP) inhibitor. Methods A discrete-choice experiment elicited pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7db889c72b962dae6ce1e5fd94e76ba
https://doi.org/10.1016/j.ygyno.2020.01.026
https://doi.org/10.1016/j.ygyno.2020.01.026
Autor:
Kathleen N. Moore, Amelia Lorenzo, Kourtnie McQuillen, Laura J. Havrilesky, Valerie Galvan Turner, Angeles Alvarez Secord, Julia R. Salinaro, Robert Boccaccio, Jessie Ehrisman, Brittany A. Davidson, Megan Stemple
Publikováno v:
International Journal of Gynecologic Cancer. 30:491-497
ObjectivesNeoadjuvant chemotherapy may be considered for women with epithelial ovarian cancer who have poor performance status or a disease burden not amenable to primary cytoreductive surgery. Overlap exists between indications for neoadjuvant chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bab6e5af22e687accc4abcae19834ca0
https://doi.org/10.1136/ijgc-2019-000980
https://doi.org/10.1136/ijgc-2019-000980
Autor:
David E. Cohn, Margaret I. Liang, Angeles Alvarez Secord, Jessie Ehrisman, Elizabeth L. Jewell, Jonathan Foote, Laura J. Havrilesky
Publikováno v:
Gynecol Oncol
Objectives FDA-approved treatments for platinum-sensitive recurrent ovarian cancer (PSROC) include bevacizumab and PARP inhibitors (PARPi); clinical decisions regarding therapy must be made prior to initiating chemotherapy. Using the American Society
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d26c86cfa9ad532c447c652d9145c7ea
https://doi.org/10.1016/j.ygyno.2018.11.028
https://doi.org/10.1016/j.ygyno.2018.11.028
Autor:
Angeles Alvarez Secord, Meng Yao, Amy Loreen, Paola A. Gehrig, Debra L. Richardson, Wesley C. Burkett, A. Staley, Laura J. Havrilesky, Caitlin Carr, Amanda Jackson, Ji Son, Stephanie Ricci, Sean C. Dowdy, Rebecca L. Stone, Chad M. Michener, Jessie Ehrisman, Susie Ahn, Catherine H. Watson, Laura M. Chambers, Stephanie L. Wethington, Anna Beavis, Kaitlyn S. Griffin, Mackenzie W. Sullivan, Akila N. Viswanathan, Amanda N. Fader, Ting Tai Yen, Susan C. Modesitt, Diogo Torres, Ashley Veade
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 30(11)
BackgroundAdjuvant therapy in early-stage endometrial cancer has not shown a clear overall survival benefit, and hence, patient selection remains crucial.ObjectiveTo determine whether women with high-intermediate risk, early-stage endometrial cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033595581505da6da2de66678ee79bf1
https://pubmed.ncbi.nlm.nih.gov/32771986
https://pubmed.ncbi.nlm.nih.gov/32771986
Autor:
Diogo Torres, Paola A. Gehrig, Amy Loreen, Ji Son, Amanda Jackson, Laura M. Chambers, Susie Ahn, Debra L. Richardson, Akila N. Viswanathan, Susan C. Modesitt, Rebecca L. Stone, Caitlin Carr, Ashely Veade, Chad M. Michener, Mackenzie W. Sullivan, Leah Jager, Ting Tai Yen, Stephanie L. Wethington, Stephanie Ricci, A. Staley, Wesley C. Burkett, Amanda Nickles Fader, Angeles Alvarez Secord, Laura J. Havrilesky, Sean C. Dowdy, Jessie Ehrisman, Anna Beavis, Kaitlyn S. Griffin, Catherine H. Watson
Publikováno v:
Gynecol Oncol
Objectives Lymphovascular space invasion (LVSI) is an independent risk factor for recurrence and poor survival in early-stage endometrioid endometrial cancer (EEC), but optimal adjuvant treatment is unknown. We aimed to compare the survival of women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e91e8303993de216244a85c10d0dbeb7
https://pubmed.ncbi.nlm.nih.gov/31948730
https://pubmed.ncbi.nlm.nih.gov/31948730
Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial Cancer
Autor:
Angeles Alvarez Secord, Fidel A. Valea, Jessie Ehrisman, Paula S. Lee, Allison Hall, Brittany A. Davidson, Sara Abbott, Zach Harmon, Laura J. Havrilesky, Xuechan Li, Andrew Berchuck
Publikováno v:
International Journal of Gynecological Pathology. 37:252-255
To determine whether the processing of additional adipose tissue collected during lymph node (LN) dissection results in the identification of additional LNs during endometrial cancer (EC) staging and to determine if the division of LNs into nodal bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::529e522cd1285a13bc580e02e3d13180
https://doi.org/10.1097/pgp.0000000000000418
https://doi.org/10.1097/pgp.0000000000000418